Phase II trial of gemcitabine/carboplatin (GC) followed by paclitaxel (P) in patients with performance status=2,3 or other significant co-morbidity (HIV infection or s/p organ transplantation) in advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Bridges, B. B.
Thomas, L.
Hausner, P.
Doyle, L. A.
Bedor, M.
Smith, R.
Brahmer, J.
Edelman, M. J.
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
[2] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7661
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A new biweekly schedule of carboplatin and gemcitabine: Phase I feasibility trial in patients with advanced non-small cell lung cancer (NSCLC).
    Mancuso, A
    Migliorino, MR
    Martelli, O
    Belli, R
    Di Molfetta, M
    De Petris, L
    Di Salvia, R
    De Marinis, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 677S - 677S
  • [32] Preliminary results of a phase II trial utilizing gemcitabine in patients with advanced non-small cell lung cancer and a performance status 2.
    Neubauer, MA
    Reynolds, CH
    Joppert, M
    Whittaker, T
    Ahmad, YH
    Ghaddar, H
    Marsland, T
    Asmar, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 646S - 646S
  • [33] A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)
    Giorgio, CG
    Pappalardo, A
    Russo, A
    Giuffrida, D
    Santini, D
    Petralia, G
    Castorina, S
    Nunzio, R
    Failla, G
    Bordonaro, R
    [J]. LUNG CANCER, 2006, 51 (03) : 357 - 362
  • [34] Cell culture based sequenced gemcitabine (G), carboplatin (C) and paclitaxel (P); GCP for advanced stage IV non-small cell lung cancer (NSCLC)
    Aisner, J
    Kane, M
    Wojtaszek, C
    Joyce, M
    Lutzker, S
    [J]. LUNG CANCER, 2005, 49 : S232 - S233
  • [35] Phase II trial of gemcitabine-carboplatin-paclitaxel (GCP) as neo-adjuvant chemotherapy for operable non-small cell lung cancer (NSCLC)
    Abratt, R
    Lee, J
    Han, J
    Tsai, C
    Boyer, M
    Mok, T
    Kim, S
    Lee, J
    Brnabic, A
    Lehnert, M
    [J]. LUNG CANCER, 2005, 49 : S92 - S92
  • [36] Phase II trial of gemcitabine-carboplatin-paclitaxel (GCP) as neo-adjuvant chemotherapy for operable non-small cell lung cancer (NSCLC).
    Abratt, RP
    Lee, JS
    Han, JY
    Tsai, CM
    Boyer, M
    Mok, T
    Kim, SW
    Lee, JS
    Brnabic, AJM
    Lehnert, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 685S - 685S
  • [37] A phase II trial of pemetrexed (P) plus carboplatin (C) in patients (pts) with advanced non-small-cell lung cancer (NSCLC).
    Koshy, S
    Herbst, RS
    Obasaju, CK
    Fossella, F
    Papadimitrakopoulou, V
    Pisters, KMW
    Blumenschein, G
    Peeples, BO
    Hong, WK
    Zinner, RG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 634S - 634S
  • [38] Phase II trial of satraplatin (S) and paclitaxel (P) in first-line advanced non-small cell lung cancer (NSCLC) treatment: Final results
    Thompson, D. S.
    Spigel, D. R.
    Hainsworth, J. D.
    Jones, S. F.
    Burris, H. A., III
    Sade, L.
    Raefsky, E.
    Greco, F. A.
    Yun, S.
    Noursalehi, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] A phase IB trial of iniparib (BSI-201) in combination with carboplatin (C)/paclitaxel (P) in patients with non-small cell lung cancer (NSCLC).
    Mita, A. C.
    Mita, M. M.
    Rocha, C.
    Bradley, C. R.
    Sarantopoulos, J.
    O'Rourke, P.
    Gadgeel, S. M.
    Wozniak, A. J.
    Heath, E. I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Gemcitabine (GEM) and carboplatin (CARB) in elderly patients with advanced non-small cell lung cancer (NSCLC): Subset analysis of a randomized phase II trial.
    Masters, GA
    Nickolov, A
    Hahn, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 679S - 679S
12345